Function and malfunction of the immune cell-adipocytes axis and its modulation by natural products and probiotics

Clinical Immunology, Endocrine and Metabolic Drugs

Volumn 3, Issue 1, 2016, Pages 39-46

  Magrone, Thea ^a   Jirillo, Emilio ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Adipocytes; Adipokines; Chemokines; Cytokines; Natural products; Obesity; Probiotics

Indexed keywords

CHEMOKINE; CYTOKINE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NATURAL PRODUCT; POLYPHENOL DERIVATIVE; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; RESVERATROL; RETINOL; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VITAMIN D;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; BODY MASS; CELL FUNCTION; DIET SUPPLEMENTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; META ANALYSIS (TOPIC); MICROFLORA; MITOCHONDRIAL RESPIRATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WHITE ADIPOCYTE;

EID: 85012168703     PISSN: 22127070     EISSN: 22127089     Source Type: Journal    
DOI: 10.2174/2212707003666160610115503     Document Type: Review

References (112)

1. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006; 14(Suppl 5): 242S-249S.
2. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin re-sistance. Science 1993; 259(5091): 87-91.
3. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013; 17(6): 851-9.
4. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11(2): 85-97.
5. DiSpirito JR, Mathis D. Immunological contributions to adipose tissue homeostasis. Semin Immunol 2015; 27(5): 315-21.
6. Nedergaard J, Cannon B. The changed metabolic world with human brown adipose tissue: Therapeutic visions. Cell Metab 2010; 11(4): 268-72.
7. Wu J, Bostrom P, Sparks LM, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150(2): 366-76.
8. Tchkonia T, Thomou T, Zhu Y, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 2013; 17(5): 644-56.
9. Proenca ARG. New concepts in white adipose tissue physiology. Braz J Med Biol Res 2014; 47(3): 192-205.
10. Fried SK, Ricci MR, Russell CD, Laferrere B. Regulation of leptin production in humans. JNutr 2000; 130(12): 3127S-31S.
11. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415(6869): 339-43.
12. Paz-Filho G, Wong ML, Licinio J. Ten years of leptin replacement therapy. Obes Rev 2011; 12(5): e315-23.
13. Romacho T, Sanchez-Ferrer CF, Peiro C. Visfatin/Nampt: An adi- pokine with cardiovascular impact. Mediators Inflamm 2013; 2013: 946427.
14. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine 2010; 37(1): 11-32.
15. Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm 2009; 80: 613-33.
16. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ. Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuro-science 2002; 115(3): 879-89.
17. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316(2): 129-39.
18. Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183-90.
19. Kopelman PG. Obesity as a medical problem. Nature 2000; 404(6778): 635-43.
20. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289(1): 76-9.
21. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112(12): 1821-30.
22. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Fer- rante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12): 1796-808.
23. Castoldi A, Naffah de Souza C, Camara NO, Moraes-Vieira PM. The Macrophage Switch in Obesity Development. Front Immunol 2016; 6:637.
24. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117(1): 175-84.
25. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25(12): 677-86.
26. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8(12): 958-69.
27. Apostolopoulos V, de Courten MP, Stojanovska L, Blatch GL, Tan- galakis K, de Courten B. The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res 2016; 60(1): 43-57.
28. Wu D, Molofsky AB, Liang HE, et al Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeo-stasis. Science 2011; 332(6026): 243-7.
29. Elgazar-Carmon V, Rudich A, Hadad N, Levy R. Neutrophils transi- ently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 2008; 49(9): 1894-903.
30. Mansuy-Aubert V, Zhou QL, Xie X, et al. Imbalance between neutro- phil elastase and its inhibitor a1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab 2013; 17(4): 534-48
31. Yang H, Youm YH, Vandanmagsar B, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: Implications for systemic inflammation and insulin resistance. J Immunol 2010; 185(3): 183645.
32. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect meta- bolic parameters. Nat Med 2009; 15(8): 930-9.
33. Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15(8): 9219
34. Han JM, Levings MK. Immune regulation in obesity-associated adipose inflammation. J Immunol 2013; 191: 527-32.
35. DeFuria J, Belkina AC, Jagannathan-Bogdan M, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T- cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA. 2013; 110(13): 5133-8.
36. Wensveen FM, Jelencic V, Valentic S, et al. NK cells link obesity- induced adipose stress to inflammation and insulin resistance. Nat Immunol 2015; 16(4): 376-85.
37. Han MS, Jung DY, Morel C, et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013; 339(6116): 218-22.
38. Zhuang G, Meng C, Guo X, et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012; 125(23): 2892-903.
39. Liu PS, Lin YW, Lee B, McCrady-Spitzer SK, Levine JA, Wei LN. Reducing RIP140 expression in macrophage alters ATM infiltration, facilitates white adipose tissue browning, and prevents high-fat diet- induced insulin resistance. Diabetes 2014; 63(12): 4021-31.
40. Kanemaru K, Matsuyuki A, Nakamura Y, Fukami K. Obesity exacer- bates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice. Exp Dermatol 2015; 24(6): 436-42.
41. Fabbrini E, Cella M, McCartney SA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 2013; 145(2): 366-74.e1-3.
42. Dalmas E, Venteclef N, Caer C, et al. T cell-derived IL-22 amplifies IL-1p-driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes. Diabetes 2014; 63(6): 1966-77.
43. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116(11): 3015-25.
44. Lee JY, Zhao L, Youn HS, et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004; 279(17): 16971-9.
45. Wen H, Gris D, Lei Y, et al. Fatty acid-induced NLRP3-ASC inflam- masome activation interferes with insulin signaling. Nat Immunol 2011; 12(5): 408-15
46. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr 2007; 27: 79-101.
47. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related ki- nase and elevation of intracellular cAMP. Diabetes 2002; 51(10): 2929-35.
48. Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 2012; 61(9): 2238-47.
49. Morris DL, Cho KW, Delproposto JL, et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013; 62(8): 2762-72.
50. Winer DA, Winer S, Chng MH, Shen L, Engleman EG. B Lympho- cytes in obesity-related adipose tissue inflammation and insulin re-sistance. Cell Mol Life Sci 2014; 71(6): 1033-43.
51. Deng T, Lyon CJ, Minze LJ, et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. CellMetab 2013; 17(3): 411-22.
52. Seijkens T, Kusters P, Chatzigeorgiou A, Chavakis T, Lutgens E. Immune cell crosstalk in obesity: A key role for costimulation? Diabetes 2014; 63(12): 3982-91.
53. Kim HM, Jeong CS, Choi HS, Kawada T, Yu R. LIGHT/TNFSF14 enhances adipose tissue inflammatory responses through its interaction with HVEM. FEBS Lett 2011; 585(3): 579-84.
54. Lo JC, Wang Y, Tumanov AV, et al. Lymphotoxin beta receptor- dependent control of lipid homeostasis. Science 2007; 316(5822): 285-8.
55. Poggi M, Jager J, Paulmyer-Lacroix O, et al. The inflammatory receptor CD40 is expressed on human adipocytes: Contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 2009; 52(6): 115-263.
56. Marzulli G, Magrone T, Kawaguchi K, Kumazawa Y, Jirillo E. Fermented grape marc (FGM): Immunomodulating properties and its potential exploitation in the treatment of neurodegenerative diseases. Curr Pharm Des 2012; 18(1): 43-50.
57. Magrone T, Panaro MA, Jirillo E, Covelli V. Molecular effects elicited in vitro by red wine on human healthy peripheral blood mononuclear cells: Potential therapeutical application of polyphenols to diet-related chronic diseases. Curr Pharm Des 2008; 14(26): 2758-66.
58. Kawaguchi K, Matsumoto T, Kumazawa Y. Effects of antioxidant polyphenols on TNF-alpha-related diseases. Curr Top Med Chem 2011; 11(14): 1767-79.
59. Carpene C, Gomez-Zorita S, Deleruyelle S, Carpene MA. Novel strategies for preventing diabetes and obesity complications with natural polyphenols. Curr Med Chem 2015; 22(1): 150-64.
60. Huang CC, Tung YT, Huang WC, Chen YM, Hsu YJ, Hsu MC. Beneficial effects of cocoa, coffee, green tea, and garcinia complex supplement on diet induced obesity in rats. BMC Complement Altern Med 2016; 16(1): 100.
61. Wang S, Moustaid-Moussa N, Chen L, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014; 25(1): 1-18.
62. Hosseini B, Saedisomeolia A, Wood LG, Yaseri M, Tavasoli S. Effects of pomegranate extract supplementation on in inflammation in overweight and obese individuals: A randomized controlled clinical trial. Complement Ther Clin Pract 2016; 22: 44-50.
63. Tsutsumi C, Okuno M, Tannous L, et al. Retinoids and retinoid- binding protein expression in rat adipocytes. J Biol Chem 1992; 267(3): 1805-10.
64. Villarroya F, Giralt M, Iglesias R. Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. Int J Obes Relat Metab Disord 1999; 23(1): 1-6.
65. Sima A, Manolescu DC, Bhat P. Retinoids and retinoid-metabolic gene expression in mouse adipose tissues. Biochem Cell Biol 2011; 89(6): 578-84.
66. Duriancik DM, Lackey DE, Hoag KA. Vitamin A as a regulator of antigen presenting cells. J Nutr 2010; 140(8): 1395-9.
67. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317(5835): 256-60.
68. Jeyakumar SM, Vajreswari A, Sesikeran B, Giridharan NV. Vitamin A supplementation induces adipose tissue loss through apoptosis in lean but not in obese rats of the WNIN/Ob strain. J Mol Endocrinol 2005; 35(2): 391-8.
69. Jeyakumar SM, Vijaya Kumar P, Giridharan NV, Vajreswari A. Vitamin A improves insulin sensitivity by increasing insulin receptor phosphorylation through protein tyrosine phosphatase 1B regulation at early age in obese rats of WNIN/Ob strain. Diabetes Obes Metab 2011; 13(10): 955-8.
70. Zulet MA, Puchau B, Hermsdorff HH, Navarro C, Martinez JA. Vitamin A intake is inversely related with adiposity in healthy young adults. J Nutr Sci Vitaminol (Tokyo) 2008; 54(5): 347-52.
71. Aasheim ET, Hofso D, Hjelmesaeth J, Birkeland KI, Bohmer T. Vitamin status in morbidly obese patients: A cross-sectional study. Am J Clin Nutr 2008; 87(2): 362-9.
72. Botella-Carretero JI, Balsa JA, Vazquez C, Peromingo R, Diaz- Enriquez M, Escobar-Morreale HF. Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease. Obes Surg 2010; 20(1): 69-76.
73. Mottaghi A, Ebrahimof S, Angoorani P, Saboor-Yaraghi AA. Vitamin A supplementation reduces IL-17 and RORc gene expression in atherosclerotic patients. Scand J Immunol 2014; 80(2): 151-7
74. Neve A, Corrado A, Cantatore FP. Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clin Exp Med 2014; 14(3): 275-83.
75. Khoo AL, Chai LY, Koenen HJ, et al. Regulation of cytokine re- sponses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 2011; 164(1): 72-9.
76. Chang E, Kim Y. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes. Nutrition 2016; 1-7.
77. Marcotorchino J, Gouranton E, Romier B, et al. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 2012; 56(12): 1771-82.
78. Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: A systematic review and metaregression analysis. Nutr Res 2016; 36(3): 201-13.
79. Zhang M, Li P, Zhu Y, et al. Higher visceral fat area increases the risk of vitamin D insufficiency and deficiency in Chinese adults. Nutr Metab (Lond) 2015; 12: 50.
80. Chirumbolo S. The role of vitamin D towards immune tolerance in white adipose tissue (WAT). Endocr Metab Immune Disord Drug Targets 2015; 15(4): 277-87.
81. Jamka M, Wozniewicz M, Walkowiak J, Bogdanski P, Jeszka J, Stel- mach-Mardas M. The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: A systematic review with meta-analysis. Eur J Nutr 2015
82. Siriwardhana N, Kalupahana NS, Cekanova M, Lemieux M, Greer B, Moustaid-Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 2013; 24(4): 613-23.
83. Liu HQ, Qiu Y, Mu Y, et al. A high ratio of dietary n-3/n-6 polyun- saturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats. Nutr Res 2013; 33(10): 849-58.
84. Kuda O, Rombaldova M, Janovska P, Flachs P, Kopecky J. Cell type- specific modulation of lipid mediator's formation in murine adipose tissue by omega-3 fatty acids. Biochem Biophys Res Commun 2016; 469(3): 731-6.
85. Cavaliere G, Trinchese G, Bergamo P, et al. Polyunsaturated fatty acids attenuate diet induced obesity and insulin resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle. PLoS One 2016; 11(2): e0149033.
86. Rijkers GT, Bengmark S, Enck P, et al. Guidance for substantiating the evidence for beneficial effects of probiotics: Current status and recommendations for future research. JNutr 2010; 140(3): 671S-6S.
87. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3(4): 213-23.
88. Ley RE, Tumabaugh PJ, Klein S, Gordon JI. Microbial ecology: Hu-man gut microbes associated with obesity. Nature 2006; 444: 1022-3.
89. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environ-mental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101(44): 15718-23.
90. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444(7122): 1027-31.
91. Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut micro- biota: the hygiene hypothesis expanded? Diabetes Care 2010; 33(10): 2277-84.
92. Yoo SR, Kim YJ, Park DY, et al. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 2013; 21(12): 2571-8.
93. Park DY, Ahn YT, Park SH, et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet- induced obese mice is associated with gut microbial changes and re-duction in obesity. PLoS One 2013; 8(3): e59470.
94. Wang J, Tang H, Zhang C, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet- fed mice. ISME J 2015; 9(1): 1-15.
95. An HM, Park SY, Lee do K, et al. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis 2011; 10: 116.
96. Chen J, Wang R, Li XF, Wang RL. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br J Nutr 2012; 107(10): 1429-34.
97. Zhao X, Higashikawa F, Noda M, et al. The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat diet-induced obese mice. PLoS one 2012; 7(2): e30696.
98. Gauffin Cano P, Santacruz A, Moya A, Sanz Y. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PloS one 2012; 7(7): e41079.
99. Everard A, Matamoros S, Geurts L, Delzenne NM, Cani PD. Saccha- romyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio 2014; 5(3): e01011-14.
100. Kim SW, Park KY, Kim B, Kim E, Hyun CK. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem Biophys Res Commun 2013; 431(2): 258-63.
101. Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64(6): 636-43.
102. Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: Follow-up study from birth to 10 years. Int J Obes (Lond) 2010; 34(10): 1531-7.
103. Magrone T, Jirillo E. A broad variety of antigens contribute to the pathogenesis of atherosclerosis: How to neutralize noxious reactions in the host. Endocr Metab Immune Disord Drug Targets 2010; 10(2): 149-60.
104. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136(1):65-80.
105. Magrone T, Jirillo E. The interaction between gut microbiota and age- related changes in immune function and inflammation. Immun Ageing 2013; 10(1): 31.
106. Magrone T, Jirillo E. The interplay between the gut immune system and microbiota in health and disease: Nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 2013; 19(7): 1329-42.
107. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102(31): 11070-5.
108. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4(9): e7125.
109. Le Chatelier E, Nielsen T, Qin J, et al. Richness ofhuman gut microbiome correlates with metabolic markers. Nature 2013; 500(7464): 541-6.
110. Kong LC, Holmes BA, Cotillard A, et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS One 2014; 9(10): e109434.
111. Vitale E, Jirillo E, Magrone T. Determination of body mass index and physical activity in normal weight children and evaluation of salivary levels of IL-10 and IL-17. Clin Immunol Endocr Metab Drugs 2015; 2: 81-8.
112. Magrone T, Jirillo E. Childhood obesity: Immune response and nutritional approaches. Front Immunol 2015; 6: 76.